L-Glutamine Use in the Treatment and Prevention of Mucositis and Cachexia: A Naturopathic Perspective

Abstract

L-Glutamine (L-GLN) is considered a nonessential amino acid that has a variety of applications in naturopathic medicine. It has been postulated that in the critically ill patient, GLN becomes an essential amino acid for recovery, restoration, and repair at a cellular level. Mucositis is an intestinal mucosal damage of the gastrointestinal tract—mouth, throat, stomach, intestines, rectum, and anus—that is caused directly by chemotherapies and radiotherapies. Cancer cachexia is a significant biochemical event, which is characterized by weight loss, fatigue, and indicative of depletion of skeletal muscle GLN—a hypercatabolic state. There has been some question as to the use of GLN in this patient population because of its role as a preferred energy source not only for enterocytes and lymphocytes but for malignant cells as well.This article will address the questions of safety, efficacy, dosing, and toxicity of GLN used as an integrative therapeutic in ongoing integrative cancer treatment.

Keywords

integrative cancer treatment mucositis stomatitis cachexia diarrhea

References

Lacey JM , Wilmore DW Is glutamine a conditionally essential amino acid? Nutr Rev . 1990;48:297-309.

Erdem NZ , Yasti AC , Atli M. , et al. The effects of perioperative oral enteral support with glutamine added elemental formulas in patients with gastrointestinal cancers: a prospective randomized clinical study. Nutr Res. 2002;22:977-988.

Souba WW Glutamine and cancer. Ann Surg. 1993 :218: 715-728.

Savarese DMF , Savy G. , Vahdat L. , Wischmeyer P. , Corey B. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003;29:501-513.

Cambridge Nutraceuticals. Summary of selected research publications on the role of glutamine in oncology therapy. www.cambridgenutra.com. Accessed August 21, 2009.

Skubitz KM , Anderson PM Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med. 1996;127: 223-228.

Anderson PM , Schroeder G. , Skubitz KM Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer. 1998 ;83:1433-1439.

Anderson PM , Ramsay NK , Shu XO , et al. Effect of low dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 1998;22: 339-344.

Rouse K. , Nwokedi E. , Woodliff JE , Epstein J. , Klimberg VS Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg. 1995;221: 420-426.

10.

Kubota A. , Meguid MM , Hitch DC Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors. Cancer. 1992;69:2343-2348.

11.

Yoshida S. , Kaibara A. , Ishibashi N. , Shirouzu K. Glutamine supplementation in cancer patients. Nutrition . 2001;17:766-768.

12.

Klimberg VS , McClellan JL Glutamine, cancer, and its therapy . Am J Surg. 1996;172:418-424.

13.

Klimberg VS , Kornbluth J. , Cao Y. , Dang A. , Blossom S. , Schaeffer RF Glutamine suppresses PGE2 synthesis and breast cancer growth. J Surg Res. 1996;63:293-297.

14.

Fahr MJ , Kornbluth J. , Blossom S. , Schaeffer R. , Klimberg VS Glutamine enhances immunoregulation of tumor growth. JPEN J Parenter Enteral Nutr. 1994;18:471-476.

15.

Ziegler TR Glutamine supplementation in bone marrow transplantation. Br J Nutr. 2002;87: S9-S15.

16.

Piccirillo N. , De Matteis S. , Laurenti L. , et al. Glutamine enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica . 2003;88:192-200.

17.

Furst P. , Albers S. , Stehle P. Evidence for a nutritional need for glutamine in catabolic patients . Kidney Int. 1989;36: 5287-5292.

18.

Berthrong M. Pathological changes secondary to radiation . World J Surg. 1986;10:155-170.

19.

Godwin A. , Meister A. , O’Dwyer P. , Huang C. , Hamilton T. , Anderson M. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A. 1992; 89:3070.

20.

Klimberg V. , Nwokedi B. , Hutchins L. , et al. Does glutamine facilitate chemotherapy while reducing its toxicity? Surg Forum. 1991 ;42:16-18.

21.

Klimberg V. , Pappas A. , Nwokedi B. , et al. Effect of supplemental dietary glutamine on methotrexate concentrations in tumors. Arch Surg. 1992;127:1317-1320.

22.

Carretero J. , Obrador E. , Pellicer J. , Pascual A. , Estrela J. Mitochondrial glutathione depletion by glutamine in growing tumor cells. Free Radic Biol Med. 2000;29:913-923.

23.

Muscaritoli M. , Micozzi A. , Conversano L. , et al. Oral glutamine in the prevention of chemotherapy-induced diarrhea. Eur J Cancer. 1997;33:319-320.

24.

Daniele B. , Perrone F. , Gall C. , et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomized trial. Gut. 2001;48:28-33.

25.

Okuno S. , Woodhouse C. , Loprinzi C. , et al. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU) based chemotherapy. Am J Clin Oncol. 1999;23:258-261.

26.

Huang EY , Leung SW , Wang CJ , et al. Oral glutamine to alleviate radiation induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys. 2000;46:535-539.

27.

Schubert MM Oral mucositis in cancer patients. Oncol Special Ed. 2004;7:51-55.

28.

On-line medical dictionary. http://www.medicinenet.com/script/main/hp.asp. Accessed August 21, 2009.

29.

Garcia-de-Lorenzo A. , Zarazaga A. , Garcia-Luna P. , et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition. 2003;19:805-811.

30.

Panigrahi P. , Gewolb IH , Bamford P. , Horvath K. Role of glutamine in bacterial transcytosis and epithelial cell injury. JPEN J Parenter Enteral Nutr. 1997;21:75-80.

31.

Daniele B. , Perrone F. , Gallo C. , et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomized trial. Gut. 2001;48:28-33.

32.

Jebb SA , Osborne RJ , Maughan TS , et al. 5-fluorouracil and folinic acid induced mucositis: no effect of oral glutamine supplementation. Br J Cancer. 1994;70:732-735.

33.

Austgen TR , Dudrick PS , Sitren H. , Bland KI , Copeland E. , Souba WW The effects of glutamine enriched total parenteral nutrition on tumor growth and host tissues. Am Surg. 1990;215:107.

34.

Ward E. , Picton S. , Reid U. , et al. Oral glutamine in paediatric oncology patients: a dose finding study. Eur J Clin Nutr. 2003;57:31-36.

35.

Hornsby-Lewis L. , Shike M. , Brown P. , Klang M. , Pearlstone D. , Brennan MF L-glutamine supplementation in home total parenteral nutrition patients: stability, safety, and effects on intestinal absorption. JPEN J Parenter Enteral Nutr. 1994;18:168-273.

36.

Lowe DK , Benefell K. , Smith RJ , et al. Safety of glutamine enriched parenteral nutrient solutions in humans. Am J Clin Nutr. 1990;52:1101-1106.

37.

Zeigler TR , Young LS , Benefell K. , et al. Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med . 1992;116:821-828.

38.

Groener MG , van Ineveld BM , Byttebier G. , van Hout BA , Rutten FF An economic evaluation of Tomudex (raltitrexed) and 5-FU plus leucovorin in advanced colorectal cancer. Anticancer Drugs. 1999;10:283-288.

39.

Sonis ST , Oster G. , Fuchs H. , et al. Oral mucositis and the clinical economic outcomes of hematopoietic stem cell transplantation. J Clin Oncol. 2001 ;19:2201-2205.